| 000 | 01378 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512041422.0 | ||
| 264 | 0 | _c19890126 | |
| 008 | 198901s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/BF00561365 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKeech, A C | |
| 245 | 0 | 0 |
_aExtent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _c1988 |
||
| 300 |
_a363-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAtenolol _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVerapamil _xadministration & dosage |
| 700 | 1 | _aHarper, R W | |
| 700 | 1 | _aHarrison, P M | |
| 700 | 1 | _aPitt, A | |
| 700 | 1 | _aMcLean, A J | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 35 _gno. 4 _gp. 363-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00561365 _zAvailable from publisher's website |
| 999 |
_c3203527 _d3203527 |
||